Brief: Jupiter Neurosciences Says Co Does Not Anticipate Impact From U.S. Tariffs On Clinical-Stage Prescription Product Development
08/04/2025 14:42
April 8 (Reuters) - Jupiter Neurosciences Inc JUNS.O: JUPITER NEUROSCIENCES INC - DOES NOT ANTICIPATE IMPACT FROM U.S. TARIFFS ON CLINICAL-STAGE PRESCRIPTION PRODUCT DEVELOPMENT JUPITER NEUROSCIENCES: TO INITIATE JNS115 PARKINSON’S PHASE 2A TRIAL IN Q3 2025 Source text: ID:nGNX5LXb8C Further company coverage: JUNS.O ((Reuters.Briefs@thomsonreuters.com;))